Introduction {#S1}
============

Over the past two decades, our initial conception of eukaryotic cell architecture has been gradually altered. The original idea of solitary organelles scattered sparsely in the cytosol has been replaced by an appreciation of the close cooperation that exists between organelles. Indeed, organelles are tightly packed together and are anything but solitary. All organelles appear to have the capacity to be tethered to one another by designated structures termed membrane contact sites, and these contact sites are generated by use of tethering molecules ([@R31]; [@R51]; [@R56]). Such areas of close membrane apposition allow for the transfer of metabolites, lipids, and other molecules between the two organelles ([@R16]). One of the most studied contact sites is formed between the endoplasmic reticulum (ER) and mitochondria. In the budding yeast *Saccharomyces cerevisiae* (hereafter termed yeast), a prominent complex promoting association of the ER and mitochondria is the ER-mitochondria encounter structure (ERMES; [@R35]). ERMES is composed of four subunits: two mitochondrial subunits (Mdm10 and Mdm34), an ER localized subunit (Mmm1), and a soluble subunit (Mdm12).

One of the most closely examined roles of ERMES is the transfer of phospholipids. As mitochondria cannot synthesize most of the lipids that they require, phospholipids, sterols, and ceramide/sphingolipids must be imported from the ER. Hence, ER-mitochondria contact sites accommodate many lipid transfer factors and proteins that are involved in lipid metabolism ([@R14]). Recently, it was shown that the Mmm1-Mdm12 complex can mediate phospholipid transfer *in vitro* and that mutations in *MMM1* or *MDM12* lead to impaired phospholipid transfer through the ERMES complex *in vivo* ([@R32]). Surprisingly, ERMES mutants typically exhibit only a mild decrease in specific phospholipids at mitochondria due to the existence of compensatory mechanisms for phospholipid transfer ([@R21]; [@R30]; [@R34]; [@R37]; [@R52]). Despite the moderate effects on lipid transfer between organelles, ERMES disruption leads to a wide array of cellular phenotypes, including loss of mitochondrial morphology, increased loss of mitochondrial DNA, and reduced respiratory capacity ([@R8]; [@R26]; [@R35]; [@R62]). Why loss of ERMES causes these adverse phenotypes, including respiratory deficiency, has not yet been fully elucidated. Hence, we have focused our attention on the role of ERMES in regulating respiration.

Here, we show that cells lacking ERMES components exhibit increased mRNA levels for proteins that participate in the coenzyme Q~6~ (CoQ~6~) biosynthetic pathway. CoQ~6~ is a polyisoprenylated benzoquinone lipid that functions within the electron transport chain of the inner mitochondrial membrane of yeast. CoQ~6~ can also act as a lipophilic antioxidant ([@R3]; [@R54]). All of the steps required for the assembly of the polyisoprenoid diphosphate tail of CoQ, its ligation to aromatic ring precursors, and modification of the ring precursor are catalyzed by Coq enzymes associated with the matrix side of the mitochondrial inner membrane ([@R3]; [@R6]). Many of the these Coq polypeptides (Coq3-Coq9 and Coq11) assemble within a mega complex termed the CoQ synthome ([@R1]; [@R5]; [@R24]; [@R40]; [@R41]). Synthesis of the polyisoprenoid tail of CoQ~6~ originates from compounds that derive from the mevalonate pathway associated with the ER, suggesting that the ER-mitochondria contact site might promote movement of CoQ~6~, or its biochemical intermediates and precursors, between these two organelles.

Indeed, we show that the CoQ synthome is destabilized in ERMES mutants, and this results in transcriptionally upregulated, yet inefficient, *de novo* CoQ~6~ biosynthesis. Such compromised synthesis results in an increase of CoQ~6~-intermediates as well as accumulation of CoQ~6~ at non-mitochondrial cellular membranes. We further demonstrate that ERMES mutants harbor decreased steady-state levels of CoQ~6~ and CoQ~6~-intermediates within mitochondria. This reduced level may contribute to the respiratory deficiency. Furthermore, ERMES-mediated contacts seem to be located in proximity to specialized matrix niches where the CoQ synthome is enriched, suggesting a spatially regulated process. Our study provides new insights into the relevance of ER-mitochondria contacts to CoQ~6~ homeostasis and, more broadly, to cellular respiration.

Materials and Methods {#S2}
=====================

Strains and Plasmids {#S3}
--------------------

*Saccharomyces cerevisiae* strains and plasmids used in this study are listed in [Table S1](#SD2){ref-type="supplementary-material"} and [Table S2](#SD3){ref-type="supplementary-material"}, respectively. Yeast strains were based on strains S288C (BY4741; [@R9]) or W303 ([@R53]). Transformations of polymerase chain reaction (PCR) products into yeast cells were performed using the Li-acetate method ([@R19]; [@R29]; [@R39]). Primers were designed using Primers-4-Yeast: <http://www.weizmann.ac.il/Primers-4-Yeast/> ([@R61]).

RNA-Sequencing {#S4}
--------------

S288C (BY4741) cells were cultured overnight in a synthetic medium SD (2% \[wt/vol\] glucose, 0.67% \[wt/vol\] yeast nitrogen base with ammonium sulfate and amino acid supplements) at 30°C. W303 cells were cultured overnight in a synthetic medium SGly (3% \[wt/vol\] glycerol, 0.67% \[wt/vol\] yeast nitrogen base with ammonium sulfate and amino acid supplements) at 30°C. In the morning, cells were back-diluted to OD~600~\~ 0.01 and followed until reaching OD~600~\~ 0.2. Cells were centrifuged (3,000 *g*, 3 min), and the pellet was frozen in liquid nitrogen and stored at −80°C until further analysis.

For all samples, RNA was purified as described ([@R57]). Briefly, RNA was extracted according to a protocol of Nucleospin^®^ 96 RNA Kit (Machery-Nagel) with two modifications: Lysis was performed by adding 450 μl of lysis buffer containing 1 M sorbitol, 100 mM EDTA, and 0.45 μl lyticase (10 IU/μl) to cells in a 96 deep-well plate. The plate was then incubated for 30 min at 30°C, centrifuged (3,000 *g*, 10 min) and the supernatant was removed. In addition, dithiothreitol was used as a replacement for β-mercaptoethanol.

For S288C (BY4741) cells, RNA was fragmented, RNA molecules harboring a poly(A) were enriched, and this was followed by cDNA preparation, barcoding, and sequencing using Illumina HiSeq 2500, as described in [@R57]. For W303 cells, RNA libraries were created by reverse transcription with a barcoded poly(T). DNA-RNA hybrids were pooled, followed by use of a hyperactive variant of the Tn5 transposase for fragmentation. SDS (0.2%) was used to strip Tn5 from DNA. Following SDS treatment, samples were purified using Solid Phase Reversible Immobilization (Beckman Coulter) Beads. cDNA was then amplified using PCR and sequenced using the Illumina NextSeq 500.

Single end reads were mapped to *S. cerevisiae* genome (R64 in SGD; [@R10]) using bowtie (parameters: --best --a --m 2 --strata --5 10; [@R38]). Following alignment, reads mapped to rRNA were excluded. For S288C samples, reads were down sampled to 400,000 reads and normalized for PCR bias using the unique molecular identifier ([@R33]). For all samples, expression of each gene was the summary of reads aligned between 400 bp upstream and 200 bp downstream of the predicted open reading frame. The gene expression summary was normalized to be 1,000,000 and a gene with an expression below 10 was excluded from further analysis ([@R57]). Each sample was analyzed twice, and values shown are typically the average of the two. However, if only one sample had a value, that value was utilized.

Mitochondrial Purification {#S5}
--------------------------

Yeast wild-type and ERMES mutant cultures were cultured in YPGly (3% \[wt/vol\] glycerol, 1% \[wt/vol\] Bacto yeast extract, and 2% \[wt/vol\] Bacto peptone) at 30°C. Cells were harvested at OD~600~ \< 4.0, and mitochondria were purified with discontinuous Nycodenz as described ([@R20]). Protease inhibitor mixture (Roche Complete EDTA-free), phosphatase inhibitor cocktail set II (EMD Millipore), and phosphatase inhibitor cocktail set 3 (Sigma-Aldrich) were added to the solutions. Gradient-purified mitochondria were frozen in liquid nitrogen and stored at −80°C until further analysis. Mitochondria from yeast Δ*coq* mutants were purified in the same manner from cultures expanded in YPGal medium (2% \[wt/vol\] galactose, 0.1% \[wt/vol\] dextrose, 1% \[wt/vol\] Bacto yeast extract, and 2% \[wt/vol\] Bacto peptone).

SDS-PAGE Analysis of Steady-State Levels of Coq Polypeptides {#S6}
------------------------------------------------------------

Purified mitochondria were resuspended in SDS sample buffer consisting of 50 mM Tris, pH 6.8, 10% glycerol, 2% SDS, 0.1% bromophenol blue, and 1.33% β-mercaptoethanol and proteins were separated by SDS-PAGE on 12% Tris-glycine polyacrylamide gels. An aliquot of 25 μg of purified mitochondria, as measured by the bicinchoninic acid assay standardized using bovine serum albumin, was loaded in each lane.

Two-Dimensional Blue Native- and SDS-PAGE Analysis of CoQ Synthome {#S7}
------------------------------------------------------------------

Analyses of protein complexes by blue native (BN) gel electrophoresis were performed as previously described ([@R50]; [@R60]). Briefly, an aliquot of 200 μg protein of purified mitochondria was pelleted by centrifugation (14,000 *g*, 10 min) and solubilized at a concentration of 4 mg protein/ml on ice for 1 h with BN solubilization buffer containing 11 mM HEPES, pH 7.4, 0.33 M sorbitol, 1× NativePAGE sample buffer (Thermo Fisher Scientific), 16 mg/ml digitonin (Biosynth), Roche Complete EDTA-free protease inhibitor mixture (Roche Complete EDTA-free), phosphatase inhibitor cocktail set II, and phosphatase inhibitor cocktail set 3. The soluble fraction was obtained by centrifugation (100,000 *g*, 10 min) and the protein concentration in the supernatant was determined by bicinchoninic acid assay. NativePAGE 5% G-250 sample additive (Thermo Fisher Scientific) was added to the supernatant to a final concentration of 0.25%. The first-dimension BN gel electrophoresis was performed using NativePAGE 4-16% Bis-Tris gel 1.0 mm x 10 wells (Thermo Fisher Scientific). First-dimension gel slices were soaked in hot SDS sample buffer for 15 min before loading them onto second dimension 12% Tris-glycine polyacrylamide gels. The high molecular weight standards for first-dimension BN gel electrophoresis were obtained from GE Healthcare (Sigma-Aldrich) and the molecular weight standards for the second dimension SDS-PAGE were obtained from Bio-Rad.

Immunoblot Analyses {#S8}
-------------------

Proteins were transferred onto 0.45 μm nitrocellulose membrane (Bio-Rad). Membranes were blocked in 0.5% bovine serum albumin, 0.1% Tween 20, 0.02% SDS in phosphate-buffered saline. Membranes were probed with primary antibodies in the same blocking buffer at the dilutions listed in [Table S3](#SD4){ref-type="supplementary-material"}. IRDye 680LT goat anti-rabbit IgG secondary antibody or IRDye 800CW goat anti-mouse IgG secondary antibody (LiCOR) was used at 1:10,000 dilutions. Blot images were recorded using LiCOR Odyssey Infrared Scanner (LiCOR).

BN-PAGE and Analysis of ATP Synthase {#S9}
------------------------------------

Wild type and Δ*mdm10* of the W303 background were grown in SLac (2% \[wt/vol\] lactate, 0.67% \[wt/vol\] Bacto yeast nitrogen base without amino acids), harvested at OD~600~ \< 2.0 and isolated by differential centrifugation as described ([@R12]. BN-PAGE was performed as described earlier ([@R49]). Briefly, 100 μg mitochondria were lysed in 40 μl buffer containing digitonin (1% digitonin, 20 mM Tris-HCl, 0.1 mM EDTA, 50 mM NaCl, 10% \[vol/vol\] glycerol, 1 mM PMSF, pH 7.2). After incubation on ice for 15 min and a clarifying spin (30,000 *g*, 15 min, 2°C), 5 μl sample buffer (5% (w/v) Coomassie blue G, 500 mM 6-amino-N-caproic acid, 100 mM Bis-Tris, pH 7.0) was added. The native complexes were analyzed by electrophoresis in a 6--14% gradient of acrylamide blue native gel. Proteins were transferred to polyvinylidene fluoride membranes and proteins were further analyzed by immunodecoration.

Stable Isotope Labeling {#S10}
-----------------------

Cells were shaken overnight at 30°C in 100 ml of YPGly and diluted the next morning to an OD~600~ \~0.1 with fresh YPGly. The cultures were incubated as before until they reached an OD~600~ of 0.6. Then ethanol (as vehicle control) or 8 μg/ml of the stable isotopes ^13^C~6~-pABA or ^13^C~6~-4HB were added, and the cultures were expanded for an additional 5 h. At each time point, triplicates of 10 ml culture were harvested by centrifugation (3,000 *g*, 5 min). Cell pellets were stored at −20°C.

Lipid Extractions and Analysis of CoQ~6~ and CoQ~6~ Intermediates {#S11}
-----------------------------------------------------------------

For lipid extractions, approximately 100 μg of purified mitochondria from each strain were prepared in triplicates. The same amount of internal standard CoQ~4~ was added to all samples and standards, followed by the addition of 2 ml methanol. Lipids were extracted twice, each time with 2 ml petroleum ether. Extracted lipids were dried down with N~2~ and stored at −20°C. Lipid extraction from isotopically labeled whole cell was performed in the same way from frozen cell pellets in triplicate.

For lipid analyses, dried lipids were reconstituted in 200 μl of 0.5 mg/ml benzoquinone in order to oxidize hydroquinones to quinones. An aliquot of 20 μl of each sample was injected into a 4000 QTRAP linear MS/MS spectrometer (Applied Biosystems). Applied Biosystems software, Analyst version 1.4.2, was used for data acquisition and processing. The chromatographic separation was carried out using a Luna 5 μm phenyl-hexyl column (100 × 4.6 mm, 5 μm; Phenomenex) and a mobile phase consisted of 95:5 methanol/isopropanol solution with 2.5 mM ammonium formate as solution A and 100% isopropanol solution with 2.5 mM ammonium formate as solution B. The percentage of solution B was increased linearly from 0 to 10% over 7 min, whereby the flow rate was increased from 650 to 800 μl/min. Each sample was analyzed using multiple reaction monitoring mode. The precursor-to-production transitions monitored for each sample are listed in [Table S4](#SD5){ref-type="supplementary-material"}. The area value of each peak, normalized with the correspondent standard curve and internal standard, was referred to the total mitochondrial protein present in the sample or total OD of cells in each cell pellet. Statistical analysis was performed with GraphPad Prism with one-way analysis of variance Bonferroni's multiple comparisons test, with the Greenhouse-Geisser correction for mitochondrial lipid analyses, and with two-way analysis of variance Dunnett's multiple comparisons test for whole cell lipid analyses.

Microscopy {#S12}
----------

Yeast were cultured overnight at 30°C in either SGly for W303 cells or SD for S288C strain. In the morning, cells were back-diluted to OD~600~\~0.2 and cultured until reaching mid-logarithmic phase. Cells were then moved to glass-bottom, 384-well microscope plates (Matrical Bioscience) coated with Concanavalin A. After 20 min incubation at room temperature to enable adherence of cells to the matrix, the wells were washed with medium. Cells were then imaged at room temperature using a 60× oil lens (NA 1.4) in the VisiScope Confocal Cell Explorer system, which is composed of a Zeiss Yokogawa spinning disk scanning unit (CSU-W1) coupled with an inverted IX83 microscope (Olympus). Single--focalplane images were taken using a PCO-Edge sCMOS camera, controlled by VisiView software (GFP-488 nm, RFP-561 nm, or BFP-405 nm). Images were reviewed using ImageJ, where brightness adjustment and cropping were performed.

Results {#S13}
=======

Yeast Lacking ERMES Have Higher Levels of Transcripts for Coenzyme Q Biosynthesis Enzymes {#S14}
-----------------------------------------------------------------------------------------

To investigate how ERMES contributes to the respiratory capacity of yeast cells, we measured the transcriptional response prompted by deletion of genes encoding ERMES subunits. We performed RNA sequencing on ERMES mutants from two different yeast genetic backgrounds: W303 yeast that were cultured on medium containing glycerol (a nonfermentable carbon source), to ensure preservation of their mitochondrial DNA ([@R26]), or S288C (BY4741) yeast, in which the ERMES mutants harbor reduced levels of mitochondrial DNA, and were therefore cultured on medium containing glucose to enable fermentation (the complete list of mRNA levels in ERMES mutants is in [Table S5](#SD6){ref-type="supplementary-material"}).

When surveying transcripts which are associated with mitochondrial respiration, we noticed that the mRNA levels of most *COQ* genes involved in the biosynthesis of CoQ~6~ were elevated relative to those in the respective control, in both genetic backgrounds and irrespective of the medium used ([Figure 1(a)](#F1){ref-type="fig"} for W303 and [Figure S1(a)](#SD1){ref-type="supplementary-material"} for S288C). Of note, the mRNA levels of genes encoding for subunits of the respiration complexes did not show a consistent trend of either up- or downregulation ([Figure S1(b)](#SD1){ref-type="supplementary-material"}.

We therefore tested whether the higher mRNA levels of the *COQ* genes resulted in higher protein levels of those polypeptides, in mitochondria purified from W303 cells ([Figure 1(b)](#F1){ref-type="fig"}). We examined the steady-state levels of Coq proteins that have previously been identified as members of the CoQ synthome, as well as Coq10, which is not part of the CoQ synthome but is thought to chaperone CoQ~6~ from the synthome to sites of function ([@R2]; [@R4]). Surprisingly, we observed that the steady-state levels of all Coq proteins in the mutant cells were either similar, or even slightly reduced, relative to their amounts in control cells ([Figure 1(b)](#F1){ref-type="fig"}).

The CoQ Synthome Is Destabilized in the Absence of ERMES Subunits {#S15}
-----------------------------------------------------------------

As the overall mRNA levels of the *COQ* transcripts were higher in ERMES deletions, yet there was no major difference in protein levels, it seems that Coq proteins might be less stable in cells lacking the ERMES complex. Since most of the Coq polypeptides assemble in the CoQ synthome ([@R5]; [@R24]; [@R40]; [@R41]) and proteins may become unstable when not assembled properly into their natural complexes, we examined the CoQ synthome by two-dimensional BN-PAGE ([Figures 2](#F2){ref-type="fig"} and [S2(a)](#SD1){ref-type="supplementary-material"}). Previously, the CoQ synthome was studied when galactose was used as a carbon source ([@R24]; [@R45]). However, to match the conditions we previously used for our assays, we followed Coq4, Coq5, and Coq9 in mitochondrial lysates from glycerol-cultured W303 cells. As expected, in control cells, the CoQ synthome was represented by high molecular weight signals, spanning a size range of 140 kDa to \> 1 MDa for both Coq4 and Coq9 ([Figures 2(a) and (b)](#F2){ref-type="fig"} and [S2(a)](#SD1){ref-type="supplementary-material"}) and between 440 kDa to \>1 MDa for Coq5 ([Figure 2(b)](#F2){ref-type="fig"}). However, in the ERMES mutant strains, the majority of very large species (\>MDa), representing the CoQ synthome, was replaced by subcomplexes with apparent migration equal to or less than \~440 kDa ([Figures 2](#F2){ref-type="fig"} and [S2(a)](#SD1){ref-type="supplementary-material"}), indicating that the CoQ synthome is indeed destabilized in the absence of the ERMES complex. This is not due to a general destabilization of mitochondrial complexes, as the ATP synthase (complex V) was not affected by the absence of the ERMES subunit Mdm10 ([Figure S2(b)](#SD1){ref-type="supplementary-material"}). Furthermore, previous work did not reveal any change in the migration behavior of porin oligomers and the Tim22 complex in Δ*mdm10* strains ([@R43]). Collectively, our current results, alongside previous observations, suggest that the effect of ERMES mutants on the CoQ synthome is specific.

ERMES Deletion Strains Show Elevated *De Novo* Synthesis of CoQ~6~ and Accumulate CoQ~6~ and CoQ~6~-Intermediates in Whole Cells {#S16}
--------------------------------------------------------------------------------------------------------------------------------

To quantify how the biosynthesis of CoQ~6~ is affected by destabilization of the CoQ synthome in ERMES mutants, we measured *de novo* synthesis of CoQ~6~ *in vivo*. Yeast cells may utilize either para-aminobenzoic acid (pABA) or 4-hydroxybenzoic acid (4HB) as ring precursors of CoQ~6~ ([@R42]; [@R48]). Early-stage intermediates, hexaprenyl-aminobenzoic acid (HAB) and hexaprenyl-hydroxybenzoic acid (HHB) are derived from prenylation of pABA or 4HB, respectively. Subsequent modifications of the aromatic ring produce late-stage intermediates such as demethyl-demethoxy-Q~6~H~2~ (DDMQ~6~), and demethoxy-Q~6~H~2~ (DMQ~6~), which eventually lead to production of Q~6~H~2~ (for a schematic of the pathway, see [Figure 3(a)](#F3){ref-type="fig"}). The amino substituent on the pABA ring is removed by a combination of Arh1, Yah1, Coq6, and Coq9 ([@R23]; [@R47]) and 4-imino-demethyl-demethoxy-Q~6~H~2~ (IDDMQ~6~) and 4-imino-demethoxy-Q~6~H~2~ (IDMQ~6~) likely represent dead-end products.

To determine whether CoQ~6~ production was altered in the ERMES deletion strains, we analyzed *de novo* biosynthesis of ^13^C~6~-CoQ~6~ with ^13^C ring-labeled precursors, namely, ^13^C~6~-pABA and ^13^C~6~-4HB. Surprisingly, we saw that Δ*mdm10*, Δ*mdm12*, and Δ*mdm34* cells showed enhanced *de novo* synthesis of ^13^C~6~-CoQ~6~ ([Figure 3(b)](#F3){ref-type="fig"}). These mutants also accumulated CoQ~6~-intermediates emanating from ^13^C~6~-pABA and ^13^C~6~-4HB, whereas Δ*mmm1* cells only contained significantly higher amount of ^13^C~6~-labeled HAB and HHB, but not the other intermediates ([Figure 3(c) to (g)](#F3){ref-type="fig"}). We also measured the levels of unlabeled CoQ~6~ (which correspond to the steady-state levels) in the same samples and observed an accumulation of unlabeled CoQ~6~ and CoQ~6~-intermediates in most of the ERMES deletion mutants, regardless of the presence or absence of ^13^C-labeled precursor ([Figure S3](#SD1){ref-type="supplementary-material"}). The results suggest that the destabilized CoQ synthome in ERMES mutants results in an aberrant accumulation of CoQ~6~ as well as CoQ~6~-intermediates.

ERMES Deletion Strains Show Decreased Steady-State Levels of CoQ~6~ and CoQ~6~-Intermediates in Isolated Mitochondria {#S17}
---------------------------------------------------------------------------------------------------------------------

Although the biosynthesis of yeast CoQ~6~ occurs exclusively within mitochondria, CoQ~6~ is present in all cellular membranes ([@R6]). To focus on the status of CoQ~6~ in mitochondria, we compared the steady-state content of CoQ~6~ in mitochondria isolated from the ERMES deletion mutants to mitochondria obtained from a control strain. Although the overall cellular levels of CoQ~6~ in these mutants were increased, the steady-state levels of CoQ~6~ per unit of mitochondrial protein were significantly reduced in mitochondria isolated from Δ*mmm1*, Δ*mdm10*, or Δ*mdm12* strains ([Figure 4(a)](#F4){ref-type="fig"}). Only strains lacking Mdm34 appeared to have nearly normal levels of CoQ~6~. Isolated mitochondria from all of the ERMES deletion strains also contained lower levels of the late-stage intermediates IDMQ~6~ and DMQ~6~ ([Figure 4(b) and (c)](#F4){ref-type="fig"}, respectively). The levels of the late-stage intermediate DDMQ~6~ were reduced in all strains, though the reduction was not statistically significant ([Figure 4(d)](#F4){ref-type="fig"}). Our finding of decreased steady-state levels of CoQ~6~ and its late intermediates in isolated mitochondria suggests that the accumulation of these molecules in whole cell lipid extracts ([Figures 3](#F3){ref-type="fig"} and [S3](#SD1){ref-type="supplementary-material"}) must reside in non-mitochondrial membranes. Moreover, reduced levels of pathway product in vicinity to the enzymes may reduce feedback inhibition ([@R7]; [@R18]; [@R55]), providing an explanation for the increased rate of synthesis observed in ERMES mutants. However, feedback inhibition has not yet been reported for Coq enzymes.

In the complete absence of the CoQ synthome, strains fail to make CoQ~6~ and can only carry out the first two steps of the biosynthetic pathway, producing HAB or HHB from the prenylation reaction of pABA or 4HB, respectively, using precursors derived from the mevalonate pathway in the ER ([@R24]). Indeed, deletion of the *COQ7* gene resulted in a dramatic accumulation of HHB and HAB ([Figure 4(e) and (f)](#F4){ref-type="fig"}), as observed previously ([@R54]). Interestingly, in the strains deleted for ERMES subunits, this accumulation of early CoQ~6~-intemediates did not occur (with the exception of HHB slightly accumulating in the Δ*mdm34* strain ([Figure 4(e)](#F4){ref-type="fig"})). The difference in the accumulation phenotypes between the ERMES-deletion strains and Δ*coq7* suggests that in addition to stabilizing the CoQ synthome, ERMES has a role at an earlier stage of the pathway.

The CoQ Synthome Resides in Specific Membrane Niches in Proximity to ERMES Contacts {#S18}
-----------------------------------------------------------------------------------

Strains lacking ERMES subunits exhibit increased levels of cellular CoQ~6~ and CoQ~6~-intermediates, yet mitochondrial CoQ~6~ and CoQ~6~-intermediates are decreased and the CoQ synthome is destabilized. In addition, early pathway intermediates do not accumulate, suggesting a reduced flux of precursors from the ER. We wondered whether the ERMES complex may play a role in organizing the CoQ synthome and the trafficking of CoQ~6~-related metabolites near ER-mitochondria contacts. As tagging Coq polypeptides with green fluorescent protein (GFP) does not impair their function ([Figure S4(a)](#SD1){ref-type="supplementary-material"}), we tagged Coq3, Coq4, Coq6, Coq9, and Coq11 with GFP and performed fluorescence microscopy. We noticed that these proteins are not distributed evenly throughout the mitochondrial matrix, but rather manifest a more punctate distribution (data not shown), suggesting that there might be discrete areas inside the mitochondrial matrix that are dedicated to the synthesis of CoQ~6~. If the assembly of the CoQ synthome depends on ERMES, in a strain deleted for ERMES the punctate pattern of the GFP-tagged Coq polypeptide should disappear. Indeed, when we GFP-tagged CoQ6 and Coq9 in a strain harboring a deletion for *MDM34*, the Coq-GFP punctate pattern was lost and the GFP signal was now spread throughout the entire mitochondrion ([Figure S4(b)](#SD1){ref-type="supplementary-material"}). However, as these mutants show dramatic alteration in mitochondrial morphology ([@R35]), it is hard to determine whether this effect is direct. To better understand the spatial relationship between ERMES and the CoQ synthome, we tagged Coq6 and Coq9 with GFP in a strain expressing Mdm34 fused to mCherry. Analyses of these cells revealed that more than 70% of the Mdm34-mCherry-marked contacts colocalized with Coq6-GFP or Coq9-GFP puncta ([Figure 5(a)](#F5){ref-type="fig"} and quantification in [Figure 5(b)](#F5){ref-type="fig"}). This colocalization was independent of genetic background and was also evident in a S288C background strain ([Figure S4(c)](#SD1){ref-type="supplementary-material"}). Our results strongly suggest that the localization of the CoQ synthome is coordinated with the position of the ER-mitochondria contact site.

Interestingly, in the yeast genome, the *COQ10* and *MDM12* genes are adjacent and likely to share a promoter ([@R10]). Indeed, SPELL analysis of transcriptional co-regulation ([@R25]) demonstrates that these two genes are co-expressed. We therefore tested whether Coq10 is involved in the positioning of the CoQ synthome next to ERMES. To this end, we removed *COQ10*, then assessed colocalization between Coq6-GFP and Mdm34-mCherry. The Coq6-GFP signal was dramatically reduced upon *COQ10* deletion, consistent with previous findings ([@R28]). Nevertheless, several Coq6-GFP-containing puncta were observed. Quantification of the colocalization between these Coq6-GFP puncta and Mdm34-mCherry revealed that the positioning of the CoQ synthome next to the ERMES complex was reduced in the *coq10* null mutant ([Figure 5(c)](#F5){ref-type="fig"} and quantification in [Figure 5(d)](#F5){ref-type="fig"}). Our results suggest that the positioning of the CoQ synthome within mitochondria is a regulated process which depends upon the presence of Coq10.

Discussion {#S19}
==========

Contact sites play a critical role in shaping cellular architecture, and their facilitation of small molecule transfer between organelles enables tight regulation of biochemical pathways. In this study, we show that ERMES, an ER-mitochondria contact site tether, plays a key role in regulating CoQ~6~ biosynthesis and distribution.

The ERMES complex appears to impact CoQ~6~ synthesis on two levels. First, absence of the ERMES complex leads to destabilization of the CoQ synthome, perturbed CoQ~6~ synthesis, and altered distribution of CoQ~6~ and its precursors. Second, there is a clear spatial coordination of the ERMES complex with the CoQ synthome ([Figure 5(e)](#F5){ref-type="fig"}). It is possible that ERMES may directly impact the CoQ synthome; however, there is no evidence showing direct interaction of ERMES subunits with known members of the CoQ synthome. We also note that the effects of ERMES disruption on the synthome and CoQ~6~ biogenesis may be, at least in part, indirectly prompted by changes to phospholipid metabolism ([@R17]; [@R27]; [@R32]; [@R36]) or by alteration of the shape and size of mitochondria ([@R22]; [@R52]; [@R62]).

We have shown that Coq10 is involved in the coordination of CoQ~6~ synthesis across the ER-mitochondria interface ([Figure 5(c) and (d)](#F5){ref-type="fig"}). *COQ10* encodes a membrane-spanning protein harboring a putative steroidogenic acute regulatory-related lipid transfer (StART) domain and a lipid-binding pocket for CoQ~6~ and late-stage CoQ~6~-intermediates ([@R2]). Although Coq10 has not been shown to be part of the CoQ synthome, it is necessary for efficient *de novo* CoQ~6~ biosynthesis and respiration ([@R2]). The co-expression of the *COQ10* and *MDM12* genes ([@R25]) might help coordinate the levels of Coq10 and ERMES to allow a better positioning of the CoQ synthome next to ER-mitochondria contact sites as they fluctuate in amount with changing cellular needs. Intriguingly, when overexpressed, Mdm12 is capable of entering the nucleus ([@R59]), raising the possibility of feedback control of the CoQ synthome-ERMES interaction. Moreover, the specific mechanism by which COQ genes are transcriptionally upregulated by ERMES disruption remains to be determined, but extensive communication exists between mitochondria and the nucleus ([@R15]), and at least one pathway by which CoQ biosynthesis can be upregulated by CoQ deficiency has been revealed in metazoans ([@R46]).

How do CoQ~6~ and CoQ~6~-intermediates escape from mitochondria and accumulate in non-mitochondrial membranes in the ERMES deletion mutants? This might be due to a direct or indirect effect. Given that many Coq proteins of the CoQ synthome can bind to CoQ~6~ or its biosynthetic intermediates, we propose that a destabilized CoQ synthome causes reduced sequestration of CoQ~6~ within mitochondria ([Figure 5(f)](#F5){ref-type="fig"}). In an alternative, yet not mutually exclusive model, disruption of ERMES mutants leads to reduced degradation of CoQ~6~ outside of mitochondria. Although CoQ~6~ degradation has not been studied extensively, it is believed that degradation of the polyisoprene tail of CoQ~6~ may be carried out in peroxisomes via both α- and β-oxidation ([@R58]). Indeed, we have previously shown that peroxisome-mitochondria (PERMIT) contact sites reside in proximity to ER-mitochondria contact sites ([@R11]), raising the possibility that loss of ERMES may also affect the capacity to degrade escaped CoQ~6~.

Excitingly, our findings are likely to have relevance to human health and disease. In mammals, the mitofusin 2 (MFN2) protein acts as a tether between the ER and mitochondria ([@R13]), and conditional *MFN2* knock-out mice exhibit impaired respiration linked to a decrease in mitochondrial levels of the mammalian ubiquinones, CoQ~9~ and CoQ~10~ ([@R44]). It is hypothesized that this phenotype is not directly related to the role of MFN2 in mitochondrial fusion as the CoQ deficiency was not linked to the morphology of the mitochondrial network. These findings further suggest that a reduction in ER-mitochondria tethering can perturb CoQ biosynthesis, suggesting parallels between the yeast and mammalian cells.
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![Cells lacking ERMES show higher levels of *COQ* mRNAs without alterations to Coq proteins.\
(a) Levels of mRNAs of the indicated *COQ* genes were measured in different W303-based strains deleted for ERMES subunits (Δ*mmm1*, Δ*mdm10*, Δ*mdm12* Δ*mdm34*), and a control strain, during growth in medium containing glycerol. The majority of *COQ* biosynthetic genes show higher mRNA levels compared to the control. Values are averages of two biological repeats. (b) Immunoblotting for steady-state levels of Coq polypeptides in purified mitochondria isolated from the indicated W303-based strains. Shown are mutants of the ERMES complex (Δ*mmm1*, Δ*mdm10*, Δ*mdm12*, and Δ*mdm34*), Δ*coq* (Δ*coq3*-Δ*coq10*) and a control, demonstrating that steady-state levels of the different Coq polypeptides were not dramatically altered in the ERMES deletion strains. Immunoblotting was performed with antisera against designated yeast Coq polypeptides (Coq3-Coq10), Mdh1 as a mitochondrial marker, and Sec62 as an ER marker. Arrows denote the corresponding protein in their respective blots. Images are representative gels from at least two biological replicates.](emss-82254-f001){#F1}

![The CoQ synthome is destabilized in the absence of ERMES subunits.\
(a) Two-dimensional Blue Native-SDS-PAGE gel electrophoresis analysis of the CoQ synthome in mitochondria from ERMES mutants or from a wild-type (WT) control strain. Gels were immunoblotted against Coq4. In the control sample, the CoQ synthome appears as complexes ranging from 232 kDa to \>1 MDa (the positions of the synthome is marked by the yellow arrow), while in the Δ*ERMES* strains, the high molecular weight signal is replaced by a signal dispersed over a range of smaller molecular weights (indicated by brackets). The relevant band was identified by comparing the bands in the WT and Δ*coq4* lanes. The red asterisk (\*) indicates a discrete nonspecific signal observed with the antisera to Coq4. (b) Two-dimensional Blue Native-SDS-PAGE gel electrophoresis was performed as described in (a). Mitochondria from Δ*coq5* strain were used to identify specific bands (Coq9 is also destabilized and undetectable in the Δ*coq5* strain). Gels were immunoblotted against Coq5 and Coq9. The strong Coq5 and Coq9 bands in the higher molecular weight (\>669 kDa) in the control sample (indicated by yellow arrows) are weaker in the Δ*ERMES* strains and are replaced by an additional diffuse signal in the lower molecular weights (indicated by brackets).](emss-82254-f002){#F2}

![Biosynthesis of CoQ~6~ and CoQ~6~-intermediates is increased in cells lacking the ERMES complex.\
(a) Schematic representation of selected steps of the CoQ~6~ biosynthesis pathway. CoQ~6~-intermediates that were analyzed using mass spectrometry (MS) are indicated in green text. (b-g) MS-MS analysis for CoQ~6~ and CoQ~6~-intermediates in whole cell lipid extracts from W303 control, Δ*mmm1*, Δ*mdm10*, Δ*mdm12*, and Δ*mdm34* strains. ^13^C~6~-CoQ~6~ and ^13^C~6~-CoQ~6~-intermediates derived from ^13^C~6~-pABA are depicted in red, while the ^13^C~6~-CoQ~6~ and ^13^C~6~-CoQ~6~-intermediates derived from ^13^C~6~-4HB are depicted in blue. The biosynthesis of ^13^C~6~-CoQ~6~ (b) is increased in Δ*mdm10*, Δ*mdm12*, and Δ*mdm34* strains labeled with ^13^C~6~-pABA or ^13^C~6~-4HB. The biosynthesis of ^13^C~6~-HHB (c) and ^13^C~6~-HAB (d) is significantly higher in all the ERMES deletion strains. The *de novo* levels of demethyl-demethoxy-Q~6~ (^13^C~6~-DDMQ~6~) (e), 4-imino-DMQ~6~ (^13^C~6~-IDMQ~6~) (f), and demethoxy-Q~6~ (^13^C~6~-DMQ~6~) (g) are significantly increased in Δ*mdm10*, Δ*mdm12*, and Δ*mdm34* strains, with the exception of ^13^C~6~-DMQ~6~ in Δ*mdm34* that did not change after the labeling with ^13^C~6~-4HB. Values are the mean of three repeats. The error bar indicates ±SD. Statistically significant differences between control (WT) and each of the ERMES mutants are represented by \*, *p* \< .05; \*\*, *p* \< .01; \*\*\*, *p* \< .001, and \*\*\*\*, *p* \< .0005. HHB = hexaprenyl-hydroxybenzoic acid; HAB = hexaprenyl-aminobenzoic acid; CoQ = Coenzyme Q; DDMQ = demethyl-demethoxy-Q; DMQ = demethoxy-Q; IDMQ = 4-imino-demethoxy-Q.](emss-82254-f003){#F3}

![Mitochondria from ERMES mutants show less CoQ~6~ and CoQ~6~-intermediates.\
(a-f) Targeted MS-MS analyses for CoQ~6~ and CoQ~6~-intermediates from purified mitochondria from W303 wild-type (WT) control, ERMES mutants (Δ*mmm1*, Δ*mdm10*, Δ*mdm12*, and Δ*mdm34*) as well as Δ*coq7*, which was included as a negative control. Levels of (a) CoQ~6~ were significantly reduced in all ERMES deletion strains except for Δ*mdm34*. Levels of (b) IDMQ~6~ and (c) DMQ~6~ were significantly reduced in all ERMES deletion strains. Levels of (d) DDMQ~6~ were not significantly changed. Levels of (e) HHB and (f) HAB were significantly higher in the Δ*coq7* strain; however, ERMES deletion strains did not show an accumulation of either HHB or HAB (with the exception of Δ*mdm34* accumulating HHB). Values are means of three biological repeats. The error bar indicates ±SD. Statistically significant differences between the control and each of the ERMES mutants are represented by \*, *p* \< .05; \*\*, *p* \< .01; \*\*\*, *p* \< .001; and \*\*\*\*, *p* \< .0005. n.d. = not detected. HHB = hexaprenyl-hydroxybenzoic acid; HAB = hexaprenyl-aminobenzoic acid; CoQ = Coenzyme Q; DDMQ = demethyl-demethoxy-Q; DMQ = demethoxy-Q; IDMQ = 4-imino-demethoxy-Q.](emss-82254-f004){#F4}

![Members of the CoQ synthome reside in a matrix niche that underlies the ERMES complex.\
(a) Yeast cells expressing the indicated GFP-tagged Coq protein, the ERMES component Mdm34 tagged with mCherry, and a marker for the mitochondrial matrix (blue fluorescent protein \[BFP\] fused to a mitochondrial targeting sequence \[MTS\]) were imaged using fluorescence microscopy. Mitochondrial Coq foci that underlie ERMES are indicated by arrows. Scale bar = 5 μM. (b) Quantification of (a), for each cell, the Coq-GFP foci were identified. Then the proximity between each Mdm34-mCherry puncta and Coq-GFP was assessed. *n* = 100 Mdm34-mCherry puncta. (c) Yeast cells expressing Coq~6~-GFP, Mdm34-mCherry, and a MTS-BFP were imaged using fluorescence microscopy on either control or Δ*coq10* background. Scale bar = 5 μM. (d) Quantification of (c). The proximity between each Mdm34-mCherry puncta and the Coq6-GFP signal was examined. *n* = 100 Mdm34-mCherry puncta. (e) Schematic representation of the colocalization of ERMES and the CoQ synthome. Coq6 and Coq9, which were visualized in (a), are highlighted in orange. (f) A suggested model for the retention of CoQ~6~ and CoQ~6~-intermediates inside mitochondria: Under normal conditions, the CoQ synthome is well assembled and CoQ~6~ biosynthesis (represented by the red arrow) occurs efficiently inside mitochondria. This catalytic efficiency ensures that early- and late-stage CoQ~6~-intermediates do not accumulate, and optimal funneling through the pathway reduces loss across the mitochondrial outer membrane and into the rest of the cell. When the ERMES complex is absent, the stability of the CoQ synthome is compromised. A partially destabilized CoQ synthome underlies inefficient CoQ biosynthesis, leading to leakage of early- and late-stage CoQ~6~-intermediates. OM = outer membrane, IM = inner membrane; GFP = green fluorescent protein; BFP = blue fluorescent protein; MTS = mitochondrial targeting sequence; ER = endoplasmic reticulum; ERMES = ER mitochondria encounter structure; HHB = hexaprenyl-hydroxybenzoic acid; HAB = hexaprenyl-aminobenzoic acid; CoQ = Coenzyme Q; DDMQ= demethyl-demethoxy-Q; DMQ = demethoxy-Q; IDMQ = 4-imino-demethoxy-Q.](emss-82254-f005){#F5}
